Oak Thistle’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10M Buy
38,033
+9,683
+34% +$2.55M 0.92% 3
2026
Q2
$6.26M Buy
28,350
+13,887
+96% +$3.84M 0.61% 24
2026
Q1
$4.27M Buy
+14,463
New +$4.3M 0.41% 54
2025
Q3
– Sell
-1,732
Closed -$477K – 487
2025
Q2
$477K Sell
1,732
-7,620
-81% -$2.07M 0.07% 377
2025
Q1
$2.48M Buy
+9,352
New +$2.31M 0.5% 50
2024
Q2
– Sell
-2,728
Closed -$587K – 319
2024
Q1
$587K Buy
+2,728
New +$573K 0.53% 40
2023
Q4
– Sell
-2,306
Closed -$462K – 471
2023
Q3
$462K Buy
+2,306
New +$458K 0.14% 310
2022
Q2
– Sell
-2,095
Closed -$499K – 218
2022
Q1
$499K Buy
+2,095
New +$492K 0.26% 167

Other funds holding CME

Oak Thistle's CME Position: Q3 2026 in Review

Oak Thistle increased its CME Group (CME) stake by 34% in Q3 2026, buying an estimated $2.55M and bringing the position to 38,033 shares worth $10M. The position accounts for 0.92% of the portfolio, ranked #3.

Oak Thistle first reported a position in CME in Q1 2022 and has held it in 8 quarters since. 1,503 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Oak Thistle held 38,033 shares of CME Group worth $10M as of Q3 2026.
  • Oak Thistle bought 9,683 CME Group shares in Q3 2026, an estimated $2.55M.
  • CME Group made up 0.92% of Oak Thistle's portfolio in Q3 2026, its #3 holding.
  • Oak Thistle first reported a position in CME Group in Q1 2022 and has held it in 8 quarters since.
  • 1,503 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.